Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 29, 2020LeukemiaOpen Access

COVID-19 among fit patients with CLL treated with venetoclax-based combinations

View Full Paper
Ask AI
Bookmark
Share

Authors

MFMoritz FürstenauPLPetra LangerbeinsNSNisha De Silva

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Fürstenau et al. (2020) studied this question.

synapsesocial.com/papers/6aaa0fe1247ec6c946482414https://doi.org/10.1038/s41375-020-0941-7
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Distinct immune composition in lymph node and peripheral blood of CLL patients is reshaped during venetoclax treatment2019 · 110 citations
  2. 2Perturbation of the normal immune system in patients with CLL2015 · 391 citations
  3. 3T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production2012 · 524 citations
  4. 4Estimates of the severity of coronavirus disease 2019: a model-based analysis2020 · 4,177 citations
  5. 5Protective role of Bruton tyrosine kinase inhibitors in patients with chronic lymphocytic leukaemia and COVID‐192020 · 87 citations